Therapeutic Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy: Clinical Report
Summary
This AAP clinical report updates neonatal HIE care. The primary abstract supports cooling eligible infants born at ≥36 weeks within 6 hours for 72 hours, with neuromonitoring, neuroimaging and developmental follow-up.
The retrieved official society summary clarifies selected later-presenting and younger infants and emphasizes coordinated recognition and transfer. This record covers that summary, rather than a full guideline appraisal.
Why it matters
An ED encountering a newborn with suspected HIE should urgently contact a cooling center. Presentation beyond 6 hours should prompt specialist assessment rather than automatic dismissal of possible eligibility.
Study at a glance
- Design
- Guideline
- Population
- Newborns with suspected moderate-to-severe hypoxic-ischemic encephalopathy.
- Sample size
- Not applicable
- Intervention
- Specialist-directed therapeutic hypothermia and coordinated transfer.
- Comparator
- Clinical-report recommendations; no new randomized comparison.
- Primary endpoint
- Prevention of death or moderate-to-severe neurodevelopmental impairment.
Key recommendations
- Standard approach: initiate within 6 hours, target 33.5°C and continue 72 hours.
- At 35 0/7–35 6/7 weeks, treatment may be considered after family discussion; below 35 weeks it is not recommended.
- At 6–24 hours, selected moderate-to-severe HIE cases may be considered after discussing potentially small benefits and risks.
- Mild HIE: evidence is insufficient. Avoid hyperthermia even when cooling is unsuitable.
- Transport cooling requires strict protocols. Continuous neuromonitoring and access to pediatric neurology are emphasized.
Limitations
The complete report was not retrieved: its page presented CAPTCHA. Detailed eligibility scoring, exclusion criteria, adverse-event estimates and underlying trials remain unreviewed; use the receiving center’s protocol.
Recommendation strength
AAP recommendations; formal GRADE certainty was not established from reviewed material.
Read the primary source
Full text: Official society summary available.
Original sourcePMID: 41581784
Material reviewed: official society summary.
Source retrieved Oct 30, 2026. Official AAP News summary retrieved in full: https://publications.aap.org/aapnews/news/34085/AAP-report-provides-update-on-therapeutic . Primary publisher indexed abstract/date and PubMed identifiers corroborated. DOI-specific correction/retraction search found no separate notice; full-report evidence and safety appraisal remains queued.
Corrections & review history
No corrections recorded. Human review: not yet human-reviewed.